The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Open accessAbstract
The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [107]
In the citing paper
“Insulin resistance in skeletal muscle is manifested by decreased insulin-stimulated glucose uptake and results from impaired insulin signaling and multiple post-receptor intracellular defects including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The ability of insulin to activate insulin receptor and IRS-1 tyrosine phosphorylation in muscle in obese nondiabetic subjects is modestly reduced; whereas in type 2 diabetics insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation are severely impaired [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“In insulin-resistant obese nondiabetic subjects, in the NGT insulin resistant offspring of two diabetic parents, and in type 2 diabetic subjects, a substantial decrease in insulin receptor tyrosine phosphorylation has been demonstrated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The decrease in insulin-stimulated association of the p85 regulatory subunit of PI3K with IRS-1 is closely correlated with the reduction in insulin-stimulated muscle glycogen synthase activity and in vivo insulin-stimulated glucose disposal [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Intact stimulation of the MAPK pathway by insulin in the presence of insulin resistance in the PI3K pathway may play an important role in the development of atherosclerosis [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Under basal conditions, total glycogen synthase activity in type 2 diabetic subjects is reduced, and the ability of insulin to activate glycogen synthase is severely impaired [7, 215–217].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Self-citationMeasurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Effect of physical exercise on sensitivity and responsiveness to insulin in humans
Mikines, K. J., Sonne, B., Farrell, P. A., Tronier, B., & Galbo, H. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e248 · Cited by 538
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Ren, J., Semenkovich, C. F., Gulve, E. A., Gao, J. H., & Holloszy, J. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36636-x · Cited by 416
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Nyomba, 1990, Am J Physiol, 258, E964
- Hayashi, 1997, Am J Physiol, 273, E1039
- Koval, 1998, Am J Physiol, 274, E304
- O’Doherty, 1994, Am J Physiol, 266, E171
- Mikines, 1988, Am J Physiol, 254, E248
- Goodyear, 1995, Am J Physiol, 268, E987
- Zorzano, 1986, Am J Physiol, 251, E664
- Kochan, 1979, Am J Physiol, 236, E660
Cited by
Sorted by citations
Items 501–600 of 997
PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
Badran, M., & Gozal, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105516 · Cited by 38
Type 2 Diabetes: An Expanded View of Pathophysiology and Therapy
Unger, J., & Parkin, C. G. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2152 · Cited by 36
Xu, L., Wei, Y., Dong, D., Yin, L., Qi, Y., Han, X., Xu, Y., Zhao, Y., Liu, K., & Peng, J. (2014) · RSC Advances · doi:10.1039/c4ra03948c · Cited by 36
Day, S. E., Coletta, R. L., Kim, J. Y., Campbell, L. E., Benjamin, T. R., Roust, L. R., Filippis, E. A. D., Dinu, V., Shaibi, G. Q., Mandarino, L. J., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0246-x · Cited by 36
Self-citationVascular Dysfunction in Horses with Endocrinopathic Laminitis
Morgan, R., Keen, J., Walker, B. R., & Hadoke, P. W. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163815 · Cited by 36
High HOMA-IR Index in Healthcare Shift Workers
Ledda, C., Cinà, D., Matera, S., Mucci, N., Bracci, M., & Rapisarda, V. (2019) · Medicina · doi:10.3390/medicina55050186 · Cited by 37
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes
Raimundo, A., Ferreira, S., Tomás-Barberán, F. A., dos Santos, C. N., & Menezes, R. (2021) · Nutrients · doi:10.3390/nu13124285 · Cited by 40
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 37
Pelletier, A., Tardif, A., Gingras, M., Chiasson, J., & Coderre, L. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9303-7 · Cited by 36
Østergård, T., Jessen, N., Schmitz, O., & Mandarino, L. J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-031 · Cited by 36
Self-citationGuo, X., Yoshitomi, H., Gao, M., Qin, L., Duan, Y., Sun, W., Xu, T., Xie, P., Zhou, J., Huang, L., et al. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-52 · Cited by 37
Petersson, S. J., Christensen, L. L., Kristensen, J. M., Kruse, R., Andersen, M., & Højlund, K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0006 · Cited by 35
Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 38
Advanced-glycation end products in insulin-resistant states
Soldatos, G., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0081-5 · Cited by 35
Sung, K., Lim, S. K., & Rosenson, R. S. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.89 · Cited by 35
DeFronzo, R. A., Mehta, R. J., & Schnure, J. J. (2013) · Hospital Practice · doi:10.3810/hp.2013.04.1062 · Cited by 35
Self-citationCan Exercise Minimize Postprandial Oxidative Stress in Patients with Type 2 Diabetes?
Tucker, P. S., Fisher‐Wellman, K. H., & Bloomer, R. J. (2008) · Current Diabetes Reviews · doi:10.2174/157339908786241160 · Cited by 35
Nagareddy, P. R., MacLeod, K. M., & McNeill, J. H. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq030 · Cited by 36
Modulation of Insulin Signaling in Human Skeletal Muscle in Response to Exercise
Kirwan, J. P., & Jing, M. X. (2002) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200204000-00008 · Cited by 35
Thiazolidinedione regulation of smooth muscle cell proliferation
Bruemmer, D., & Law, R. E. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.014 · Cited by 35
Acute, Muscle-Type Specific Insulin Resistance Following Injury
Thompson, L. H., Kim, H. T., Ma, Y., Kokorina, N. A., & Messina, J. L. (2008) · Molecular Medicine · doi:10.2119/2008-00081.thompson · Cited by 34
Biological signalling activity measurements using mass spectrometry.
Cutillas, P., & Jorgensen, C. (2011) · Biochemical Journal · doi:10.1042/bj20101974 · Cited by 30
Sato, S., Ogura, Y., Tajrishi, M. M., & Kumar, A. (2014) · The FASEB Journal · doi:10.1096/fj.14-260703 · Cited by 32
Hodroj, W., Legedz, L., Foudi, N., Cerutti, C., Bourdillon, M. C., Feugier, P., Beylot, M., Randon, J., & Bricca, G. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254814.63768.3b · Cited by 34
Insulin resistance in penile arteries from a rat model of metabolic syndrome
Contreras, C., Sánchez, A., Martínez, M. P., Raposo, R., Climent, B., García‐Sacristán, A., Benedito, S., & Prieto, D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00825.x · Cited by 34
Madonna, R., Massaro, M., Pandolfi, A., Consoli, A., & Caterina, R. D. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000312 · Cited by 34
Insulin Resistance: Pathophysiology and Rationale for Treatment
Muntoni, S., & Muntoni, S. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000323395 · Cited by 34
Zhang, R., Liu, S., Guo, B., Chang, L., & Li, Y. (2014) · Pharmacology · doi:10.1159/000369171 · Cited by 33
Li, J., Ren, Y., Shi, E., Tan, Z., Xiong, J., Yan, L., & Jiang, X. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.02.016 · Cited by 33
Mukaida, S., Evans, B. A., Bengtsson, T., Hutchinson, D. S., & Sato, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.022 · Cited by 33
Ma, Y., Gao, J., Yin, J., Gu, L., Liu, X., Su, C., Huang, Q., Lu, H., Yang, Y., Zhou, H., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01030 · Cited by 33
Introduction???Preventing Insulin Resistance through Exercise: A Cellular Approach
Hawley, J. A., & Houmard, J. A. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000132382.95142.71 · Cited by 33
CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance
Petersen, M. C., & Jurczak, M. J. (2016) · The Journal of Physiology · doi:10.1113/jp271677 · Cited by 32
Kokaji, T., Hatano, A., Ito, Y., Yugi, K., Eto, M., Morita, K., Ohno, S., Fujii, M., Hironaka, K., Egami, R., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1236 · Cited by 29
Diabetes Management in the Kidney Patient
Garg, R., & Williams, M. E. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.11.001 · Cited by 32
PPAR Agonists and Cardiovascular Disease in Diabetes
Calkin, A. C., & Thomas, M. C. (2008) · PPAR Research · doi:10.1155/2008/245410 · Cited by 30
Skeletal muscle mitochondrial dysfunction & diabetes.
Raghavakaimal, S., & Nair, K. S. (2007) · PubMed · Cited by 31
Cersósimo, E., Xu, X., & Musi, N. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00022.2011 · Cited by 31
de Laat, M. A., McGowan, C. M., Sillence, M. N., & Pollitt, C. C. (2010) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2010.04.003 · Cited by 31
Zawalich, W. S., Tesz, G. J., & Zawalich, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105008200 · Cited by 31
Rensing, K. L., de Jager, S. C. A., Stroes, E. S. G., Vos, M., Twickler, M., Dallinga‐Thie, G. M., de Vries, C. J. M., Kuiper, J., Bot, I., & von der Thüsen, J. H. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt252 · Cited by 30
Pathophysiology of the proatherothrombotic state in the metabolic syndrome
Navarro, H. G. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s57 · Cited by 32
Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
Tentolouris, A., Eleftheriadou, I., Tzeravini, E., Tsilingiris, D., Paschou, S. Α., Siasos, G., & Tentolouris, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190119154152 · Cited by 31
Gavete, M. L., Martín, M. Á., Álvarez, C., & Escrivá, F. (2005) · Endocrinology · doi:10.1210/en.2004-1658 · Cited by 31
Sugita, M., Sugita, H., & Kaneki, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000140778.53811.20 · Cited by 30
Monnier, L., Colette, C., Michel, F., Cristol, J., & Owens, D. R. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1174 · Cited by 30
Exercise training increases ERK2 activity in skeletal muscle of obese Zucker rats
Osman, A. A., Hancock, J., Hunt, D. G., Ivy, J. L., & Mandarino, L. J. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.2.454 · Cited by 30
Self-citationRole of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism
Li, M. E., Lauritzen, H. P. M. M., O'Neill, B. T., Wang, C., Cai, W., Brandão, B. B., Sakaguchi, M., Tao, R., Hirshman, M. F., Softic, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11265-y · Cited by 31
Self-citationFakhrzadeh, H., Alatab, S., Sharifi, F., Mirarefein, M., Badamchizadeh, Z., Ghaderpanahi, M., Taheri, A. P. H., & Larijani, B. A. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01829.x · Cited by 29
Beck‐Nielsen, H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2337 · Cited by 30
Altered hepatic insulin signalling in male offspring of obese mice
Martin‐Gronert, M. S., Fernandez‐Twinn, D. S., Poston, L., & Ozanne, S. E. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000231 · Cited by 29
Enhanced insulin signaling via Shc in human breast cancer
Finlayson, C. A., Chappell, J., Leitner, J. W., Goalstone, M. L., Garrity, M., Nawaz, S., Ciaraldi, T. P., & Draznin, B. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00311-1 · Cited by 29
Isenović, E. R., Kedees, M. H., Haidara, M. A., Trpković, A., Mikhailidis, D. P., & Marché, P. (2010) · Angiology · doi:10.1177/0003319709358693 · Cited by 29
Dissociation between metabolic and vascular insulin resistance in aging
Schulman, I. H., Zhou, M.-S., Jaimes, E. A., & Raij, L. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00138.2007 · Cited by 28
Formoso, G., Tomo, P. D., Andreozzi, F., Succurro, E., Silvestre, S. D., Prudente, S., Perticone, F., Trischitta, V., Sesti, G., Pandolfi, A., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq255 · Cited by 29
de Freitas, M. S., Souza, É. P. G., da Silva, S. V., Kaezer, A. D. R., Vieira, R. D. S., Moura, A. S., & Barja‐Fidalgo, C. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00096-6 · Cited by 29
Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes.
Pedersen, A. J. T., Hingst, J. R., Friedrichsen, M., Kristensen, J. M., Højlund, K., & Wojtaszewski, J. F. P. (2015) · Diabetologia · doi:10.1007/s00125-015-3582-z · Cited by 28
Салухов, В. В., Khalimov, Y. S., Борисович, Ш. С., & Kadin, D. V. (2018) · Diabetes Mellitus · doi:10.14341/dm9570 · Cited by 34
Rroji, M., Spahia, N., Figurek, A., & Spasovski, G. B. (2025) · Biomedicines · doi:10.3390/biomedicines13030728 · Cited by 31
Harmancey, R., Haight, D. L., Watts, K. A., & Taegtmeyer, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.673988 · Cited by 28
Metabolic Syndrome and Prediabetes
Babu, A. R., & Fogelfeld, L. A. (2006) · Disease-a-Month · doi:10.1016/j.disamonth.2006.03.001 · Cited by 27
Effect of acute exercise on glycogen synthase in muscle from obese and diabetic subjects
Jensen, J., Tantiwong, P., Stuenæs, J. T., Molina‐Carrión, M., DeFronzo, R. A., Sakamoto, K., & Musi, N. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00658.2011 · Cited by 28
Self-citationThe Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
Wang, N., Li, T., & Han, P. (2015) · Journal of Diabetes Research · doi:10.1155/2016/9261259 · Cited by 28
Wadley, G. D., Konstantopoulos, N., Macaulay, L. S., Howlett, K. F., GARNHAM, A. P., Hargreaves, M., & Cameron‐Smith, D. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00821.2006 · Cited by 28
Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism
Liu, Z., Lu, J., Sha, W., & Lei, T. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1509884 · Cited by 34
Endothelial dysfunction in African-Americans
Patel, P. D., Velazquez, J. L., & Arora, R. R. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.007 · Cited by 27
Leber, A. J., Hontecillas, R., Tubau‐Juni, N., Zoccoli-Rodriguez, V., Goodpaster, B. H., & Bassaganya-Riera, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-67300-2 · Cited by 30
Atherogenesis and Diabetes: Focus on Insulin Resistance and Hyperinsulinemia
Madonna, R., & Caterina, R. D. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.11.009 · Cited by 27
Insulin Resistance and Atherosclerosis
Raghavan, V. A. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.014 · Cited by 27
Ruiz‐Alcaraz, A. J., Lipina, C., Petrie, J. R., Murphy, M. J., Morris, A. D., Sutherland, C. D., & Cuthbertson, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056928 · Cited by 27
Guardado‐Mendoza, R., Jiménez-Ceja, L. M., Majluf‐Cruz, A., Kamath, S., Fiorentino, T. V., Casiraghi, F., Velazquez, A. O. C., DeFronzo, R. A., Dick, E. J., Davalli, A. M., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.205 · Cited by 27
Self-citationContreras, C., Sánchez, A., García‐Sacristán, A., Martínez, M. C., Andriantsitohaina, R., & Prieto, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.036 · Cited by 27
Aterogénesis y diabetes: resistencia a la insulina e hiperinsulinemia
Madonna, R., & Caterina, R. D. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.11.010 · Cited by 27
Kwintkiewicz, J., Foyouzi, N., Piotrowski, P., Rzepczynska, I. J., & Dulęba, A. J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.020 · Cited by 27
Kumar, N., & Dey, C. S. (2002) · Journal of Experimental Biology · doi:10.1242/jeb.205.23.3739 · Cited by 27
Insulin resistance, hyperleptinemia and endothelial dysfunction in coronary restenosis
Piatti, P., & Monti, L. D. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.004 · Cited by 27
Mels, C. M. C., Schutte, A. E., Schutte, R., Huisman, H. W., Smith, W. T., Fourie, C. M. T., Kruger, R., van Rooyen, J. M., Malan, N. T., & Malan, L. (2013) · Amino Acids · doi:10.1007/s00726-013-1611-0 · Cited by 27
Regulation of Insulin Action by Diet and Exercise
Schmidt, S. L., & Hickey, M. S. (2009) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2009.04.185 · Cited by 26
Park, S. E., Rhee, E., Park, C., Oh, K. W., Park, H., Kim, S.-W., & Lee, W. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.013 · Cited by 26
Effects of chronic hyperinsulinemia in insulin-resistant patients
Muntoni, S., Muntoni, S., & Draznin, B. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0040-z · Cited by 26
Barber, T. M., & Franks, S. (2012) · Women s Health · doi:10.2217/whe.11.94 · Cited by 26
Activation of MAP kinase by insulin and vanadate in adipocytes from young and old rats
Molero, J. C., PEREZ, C. M., Martı́nez, C., Villar, M., Andrés, A., Fermín, Y., & Carrascosa, J. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00737-7 · Cited by 26
Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function
Aziz, A., & Wheatcroft, S. B. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.20 · Cited by 25
Pioglitazone and mechanisms of CV protection
Erdmann, E., & Wilcox, R. G. (2009) · QJM · doi:10.1093/qjmed/hcp168 · Cited by 25
Holle, S. K., Ciarimboli, G., Edemir, B., Neugebauer, U., Pavenstädt, H. J., & Schlatter, E. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0969-7 · Cited by 25
Non-peptidyl insulin mimetics as a potential antidiabetic agent
Nankar, R. P., & Doble, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.04.005 · Cited by 26
Stenkula, K. G., Said, L., Karlsson, M., Thorn, H., Kjølhede, P., Gustavsson, J., Söderström, M., Strålfors, P., & Nyström, F. H. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.04.011 · Cited by 25
Bedinger, D., Goldfine, I. D., Corbin, J., Roell, M. K., & Adams, S. H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221309 · Cited by 25
Li, F., Xia, K., Sheikh, M. S. A., Cheng, J., Li, C., & Yang, T. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2028 · Cited by 26
Liu, Z., Xu, L., Xu, X., Niu, Y., Saadeldeen, F. S. A., & Kang, W. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110806 · Cited by 25
Sarafidis, P. A., & Lasaridis, A. N. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00009.x · Cited by 25
Bu, Y., He, Y., Zhou, H., Liu, W. X., Peng, D., Tang, A., Tang, L., Xie, H., Huang, Q., Luo, X., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0064 · Cited by 26
Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus
Cusi, K. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0033-6 · Cited by 25
Self-citationInsulin Resistance in Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch11 · Cited by 27
Atherothrombotic risk in obesity
Vera, R. H., Vilahur, G., & Badimón, L. (2013) · Hämostaseologie · doi:10.5482/hamo-13-07-0034 · Cited by 24
S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes
He, Q., Bo, J., Shen, R., Li, Y., Zhang, Y., Zhang, J., Yang, J., & Liu, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1341750 · Cited by 24
Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity
Rovella, V., Rodia, G., Daniele, F. D., Cardillo, C., Campia, U., Noce, A., Candi, E., Della‐Morte, D., & Tesauro, M. (2021) · Nutrients · doi:10.3390/nu13020613 · Cited by 24
Potential roles of genistein in polycystic ovary syndrome: A comprehensive systematic review
Azgomi, R. N. D., Jazani, A. M., Karimi, A., & Pourreza, S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175275 · Cited by 26
Feng, X., WANG, T.-Z., CHEN, Y., LIU, J.-B., Liu, Y., & Wang, W. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1061 · Cited by 24
Metadata
- Authors
- Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Harvard University (US)
- Tulane University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Mandarino, Lawrence J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377440
- OpenAlex
- W2120852510
- Cited by
- 1,139
- References
- 48
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 19 · 2023: 27 · 2022: 35 · 2021: 45 · 2020: 33 · 2019: 35 · 2018: 24 · 2017: 37 · 2016: 52 · 2015: 54 · 2014: 53 · 2013: 57 · 2012: 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, DK02526, R01DK047936, R01DK033201, R01DK024092, R01-DK-47936)
- National Center for Research Resources (M01RR001346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, skeletal muscle, type 2 diabetes, PI3K signaling, MAPK signaling, insulin receptor, IRS-1, p85 regulatory subunit, physical activity, glucose uptake, obesity, euglycemic clamp, insulin signaling
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Phosphoproteins, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
